Approved regimen
Approved labeled regimen
Product-, indication-, and jurisdiction-specific — see the monograph
- Prostate cancer:
- Lupron Depot: 7.5 mg IM q month; 22.5 mg IM q 3 months; 30 mg IM q 4 months; 45 mg IM q 6 months
- Eligard: 7.5 mg SC q month; 22.5 mg SC q 3 months; 30 mg SC q 4 months; 45 mg SC q 6 months
- Endometriosis: Lupron Depot 3.75 mg IM q month × 6 months (or 11.25 mg IM q 3 months × 2 doses); may use with norethindrone 5 mg/day add-back
- Uterine fibroids (preoperative): Lupron Depot 3.75 mg IM q month × ≤3 months with iron
- Central precocious puberty: Individualised; weight-based dosing per label